Header Logo

Deborah Hall

Concepts (384)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Fragile X Syndrome
30
2023
188
7.930
Why?
Tremor
26
2022
104
7.330
Why?
Fragile X Mental Retardation Protein
32
2023
115
7.000
Why?
Parkinson Disease
33
2025
670
6.710
Why?
Ataxia
25
2022
76
6.270
Why?
Parkinsonian Disorders
11
2022
225
2.820
Why?
Heterozygote
11
2022
100
2.670
Why?
Trinucleotide Repeat Expansion
15
2023
45
2.470
Why?
Tinnitus
5
2020
12
2.030
Why?
Neurology
3
2022
37
1.930
Why?
Humans
110
2025
27072
1.880
Why?
Cognition Disorders
7
2021
985
1.630
Why?
Female
63
2025
15212
1.390
Why?
Research Design
6
2022
185
1.320
Why?
Male
57
2025
14772
1.300
Why?
Middle Aged
51
2025
8923
1.260
Why?
Aged
47
2025
8997
1.210
Why?
Supranuclear Palsy, Progressive
8
2020
21
1.180
Why?
Gait Disorders, Neurologic
3
2020
133
1.150
Why?
Postural Balance
5
2020
117
1.130
Why?
Executive Function
3
2018
111
1.040
Why?
Gastrointestinal Microbiome
3
2023
158
1.040
Why?
Phenotype
10
2025
312
1.030
Why?
Cerebellar Ataxia
2
2021
4
0.990
Why?
Trinucleotide Repeats
2
2018
11
0.960
Why?
Movement Disorders
4
2016
66
0.950
Why?
Health Status Disparities
1
2025
75
0.900
Why?
Cognition
6
2022
1339
0.890
Why?
Healthcare Disparities
1
2025
88
0.890
Why?
Accidental Falls
4
2020
110
0.860
Why?
Biomedical Research
2
2018
56
0.830
Why?
Exercise Therapy
3
2018
88
0.810
Why?
Attention
2
2020
124
0.770
Why?
Advance Care Planning
1
2022
11
0.760
Why?
Huntington Disease
1
2022
48
0.740
Why?
Mutation
8
2023
348
0.730
Why?
Spinocerebellar Degenerations
1
2021
4
0.730
Why?
Psychomotor Performance
2
2020
205
0.710
Why?
Patient Selection
2
2018
194
0.690
Why?
Cytidine Diphosphate Choline
1
2020
4
0.670
Why?
Nootropic Agents
1
2020
14
0.670
Why?
Delphi Technique
3
2022
25
0.660
Why?
Auditory Perception
2
2017
34
0.650
Why?
Walking
4
2020
253
0.650
Why?
Clinical Trials as Topic
2
2018
216
0.610
Why?
Hearing
2
2021
20
0.610
Why?
Quality of Life
7
2025
629
0.600
Why?
Case-Control Studies
10
2021
587
0.570
Why?
Dyskinesia, Drug-Induced
3
2023
9
0.570
Why?
Genetic Predisposition to Disease
5
2023
381
0.570
Why?
Acoustics
1
2017
19
0.570
Why?
Psychotherapy
1
2017
39
0.550
Why?
Deafness
3
2022
13
0.550
Why?
Polymerase Chain Reaction
2
2016
120
0.550
Why?
Adult
23
2022
7831
0.540
Why?
United States
6
2025
2035
0.540
Why?
Memory Disorders
2
2016
159
0.540
Why?
Severity of Illness Index
11
2020
879
0.530
Why?
Genetic Testing
6
2021
57
0.520
Why?
Cerebral Hemorrhage
4
2021
96
0.520
Why?
Antipsychotic Agents
2
2023
55
0.500
Why?
Aged, 80 and over
17
2021
4777
0.500
Why?
DNA Methylation
1
2016
161
0.480
Why?
Treatment Outcome
11
2022
3485
0.470
Why?
Neuropsychological Tests
8
2022
1196
0.440
Why?
Surveys and Questionnaires
7
2022
1144
0.430
Why?
Acoustic Stimulation
1
2013
50
0.420
Why?
Risk Factors
9
2021
2302
0.390
Why?
Speech Disorders
2
2020
10
0.390
Why?
Deep Brain Stimulation
2
2022
36
0.380
Why?
Alleles
3
2020
216
0.380
Why?
Retrospective Studies
10
2022
3538
0.370
Why?
Brain Ischemia
2
2021
63
0.370
Why?
Communication Disorders
1
2011
4
0.360
Why?
Chromosomes, Human, X
2
2009
9
0.350
Why?
Consensus
3
2022
87
0.350
Why?
Cochlear Implantation
2
2021
22
0.340
Why?
Gait
4
2020
412
0.340
Why?
Activities of Daily Living
4
2017
595
0.340
Why?
Dopamine
1
2010
82
0.340
Why?
Walking Speed
2
2022
41
0.330
Why?
Shoulder Pain
1
2010
57
0.330
Why?
Sex Chromosome Aberrations
1
2009
1
0.330
Why?
Chromosomes, Human, Y
1
2009
1
0.330
Why?
Speech Perception
2
2021
49
0.330
Why?
Levodopa
3
2023
34
0.330
Why?
Cognitive Dysfunction
2
2020
1061
0.320
Why?
DNA Repeat Expansion
2
2006
6
0.310
Why?
Prospective Studies
7
2025
1778
0.310
Why?
Quinolones
1
2009
11
0.310
Why?
Pilot Projects
3
2020
420
0.310
Why?
Motor Activity
3
2021
323
0.310
Why?
Cross-Sectional Studies
6
2020
891
0.300
Why?
Sex Factors
4
2022
464
0.290
Why?
Piperazines
1
2009
85
0.290
Why?
Observational Studies as Topic
2
2025
22
0.280
Why?
Students, Health Occupations
1
2007
4
0.280
Why?
Science
1
2007
4
0.280
Why?
Celiac Disease
1
2007
7
0.280
Why?
Dystonia
1
2007
12
0.280
Why?
Clinical Laboratory Techniques
1
2007
29
0.270
Why?
Teaching
1
2007
51
0.270
Why?
RNA, Messenger
4
2023
310
0.270
Why?
Fetal Distress
1
2006
1
0.270
Why?
Pregnancy in Diabetics
1
2006
4
0.270
Why?
Central Nervous System Agents
1
2006
7
0.270
Why?
Age of Onset
4
2016
94
0.270
Why?
Infant, Newborn, Diseases
1
2006
15
0.260
Why?
Pregnancy Complications, Cardiovascular
1
2006
17
0.260
Why?
Seizures
1
2006
67
0.250
Why?
Feces
2
2023
103
0.250
Why?
Gait Ataxia
1
2005
5
0.250
Why?
Disability Evaluation
5
2016
264
0.250
Why?
Cohort Studies
5
2023
1890
0.240
Why?
Glucosylceramidase
2
2022
15
0.240
Why?
Prion Diseases
1
2005
2
0.240
Why?
Diagnostic Errors
1
2005
28
0.240
Why?
Prions
1
2005
7
0.240
Why?
Brain
5
2022
1649
0.230
Why?
Exercise
3
2017
450
0.230
Why?
Time Factors
5
2020
1433
0.230
Why?
Intellectual Disability
1
2005
43
0.230
Why?
Hyperglycinemia, Nonketotic
1
2004
1
0.230
Why?
Neurotoxicity Syndromes
1
2004
3
0.230
Why?
Chorea
1
2004
5
0.230
Why?
Eye Movements
2
2021
11
0.230
Why?
Child
5
2022
1295
0.210
Why?
Antiparkinson Agents
1
2023
42
0.210
Why?
Corpus Callosum
1
2003
12
0.210
Why?
Basal Ganglia Diseases
1
2023
5
0.210
Why?
Diffusion Magnetic Resonance Imaging
2
2021
89
0.210
Why?
Mental Disorders
1
2005
141
0.210
Why?
Incidence
4
2020
759
0.210
Why?
Drug-Related Side Effects and Adverse Reactions
1
2023
18
0.210
Why?
Caregivers
2
2022
197
0.210
Why?
Fatty Acids, Volatile
1
2023
31
0.210
Why?
Prebiotics
1
2023
22
0.200
Why?
Career Mobility
1
2022
13
0.200
Why?
ran GTP-Binding Protein
1
2022
3
0.200
Why?
Health Facilities
1
2022
23
0.200
Why?
Homebound Persons
1
2022
6
0.200
Why?
Receptors, Urokinase Plasminogen Activator
1
2022
17
0.200
Why?
Neurosecretory Systems
1
2022
5
0.200
Why?
Glucagon-Like Peptide 1
1
2022
9
0.200
Why?
Longitudinal Studies
3
2021
1368
0.200
Why?
Mentoring
1
2022
27
0.200
Why?
Weather
2
2019
11
0.190
Why?
Advance Directives
1
2022
3
0.190
Why?
Biomechanical Phenomena
4
2020
644
0.190
Why?
Alzheimer Disease
1
2014
2109
0.190
Why?
Cerebral Infarction
1
2003
147
0.190
Why?
Documentation
1
2022
24
0.190
Why?
Subthalamic Nucleus
1
2022
19
0.190
Why?
Dopamine Agents
1
2021
11
0.190
Why?
Multiple System Atrophy
1
2022
32
0.190
Why?
Food
1
2021
34
0.190
Why?
Primary Ovarian Insufficiency
1
2021
8
0.180
Why?
Comprehension
2
2016
31
0.180
Why?
Ovary
1
2021
23
0.180
Why?
Hearing Loss, Sensorineural
1
2021
14
0.180
Why?
Cerebral Amyloid Angiopathy
2
2019
111
0.180
Why?
Hypertension
2
2019
192
0.180
Why?
Societies, Medical
2
2019
121
0.180
Why?
Chicago
2
2021
949
0.180
Why?
Martial Arts
1
2020
4
0.180
Why?
Hyperglycemia
1
2020
29
0.180
Why?
Telemedicine
1
2022
97
0.170
Why?
Neurodegenerative Diseases
1
2022
125
0.170
Why?
Prevalence
2
2020
443
0.170
Why?
Vision Disorders
1
2020
20
0.170
Why?
Menopause
1
2021
101
0.170
Why?
Hearing Loss, Unilateral
1
2020
1
0.170
Why?
Animals
5
2022
3642
0.170
Why?
Hearing Aids
1
2020
3
0.170
Why?
Blood Glucose
1
2020
104
0.170
Why?
Time and Motion Studies
1
2020
19
0.170
Why?
Chemokine CCL5
1
2019
14
0.160
Why?
Dementia
1
2005
560
0.160
Why?
Th17 Cells
1
2019
30
0.160
Why?
Predictive Value of Tests
4
2020
474
0.160
Why?
Electroencephalography
2
2013
77
0.160
Why?
Research Subjects
1
2018
10
0.160
Why?
Academies and Institutes
1
2018
11
0.160
Why?
Sample Size
1
2018
18
0.150
Why?
Health Services Accessibility
1
2020
112
0.150
Why?
Adolescent
4
2013
2172
0.150
Why?
Genotype
3
2016
346
0.150
Why?
Dopaminergic Neurons
1
2019
49
0.150
Why?
Substantia Nigra
1
2019
120
0.150
Why?
Pedigree
3
2008
65
0.150
Why?
Independent Living
1
2021
322
0.150
Why?
High-Intensity Interval Training
1
2018
1
0.150
Why?
Gene-Environment Interaction
1
2018
18
0.150
Why?
Estrogens
1
2018
25
0.150
Why?
Ibuprofen
1
2017
11
0.140
Why?
Patient Acceptance of Health Care
1
2018
77
0.140
Why?
Stakeholder Participation
1
2017
10
0.140
Why?
Endpoint Determination
1
2017
22
0.140
Why?
Fatigue Syndrome, Chronic
1
2017
3
0.140
Why?
Colorado
2
2007
4
0.140
Why?
Memory, Short-Term
2
2015
97
0.140
Why?
Exercise Test
1
2018
118
0.140
Why?
Mosaicism
1
2016
9
0.140
Why?
Siblings
1
2016
15
0.140
Why?
Health Knowledge, Attitudes, Practice
1
2018
164
0.140
Why?
Anti-Inflammatory Agents, Non-Steroidal
1
2017
110
0.130
Why?
Congresses as Topic
1
2016
32
0.130
Why?
Water Wells
1
2016
1
0.130
Why?
Uric Acid
1
2016
7
0.130
Why?
Follow-Up Studies
4
2010
1792
0.130
Why?
Epigenesis, Genetic
1
2016
83
0.130
Why?
Environmental Exposure
1
2016
17
0.130
Why?
Age Factors
4
2021
766
0.130
Why?
Occupational Diseases
1
2016
22
0.130
Why?
Computers
1
2015
17
0.130
Why?
Hip Prosthesis
1
2021
539
0.120
Why?
Early Diagnosis
1
2015
57
0.120
Why?
Chronic Disease
1
2017
415
0.120
Why?
Reaction Time
1
2015
102
0.120
Why?
DNA Mutational Analysis
2
2005
56
0.120
Why?
Monitoring, Physiologic
1
2015
68
0.120
Why?
Young Adult
3
2013
1994
0.120
Why?
Regression Analysis
1
2015
260
0.120
Why?
Range of Motion, Articular
1
2018
708
0.120
Why?
Endometrium
2
2002
8
0.120
Why?
Dopamine Agonists
2
2021
15
0.110
Why?
Breast Neoplasms
4
1997
409
0.110
Why?
Hyperkinesis
1
2013
8
0.110
Why?
Diagnosis, Computer-Assisted
1
2013
18
0.110
Why?
Auditory Pathways
1
2013
1
0.110
Why?
Audiometry, Pure-Tone
1
2013
12
0.110
Why?
England
1
2013
14
0.110
Why?
Psychoacoustics
1
2013
7
0.110
Why?
Diagnosis, Differential
2
2005
348
0.110
Why?
Disease Progression
4
2016
673
0.110
Why?
Cerebellar Diseases
1
2013
8
0.110
Why?
Registries
2
2022
189
0.110
Why?
Clinical Protocols
1
2013
57
0.100
Why?
Neuronal Plasticity
1
2013
47
0.100
Why?
Arthroplasty, Replacement, Hip
1
2021
810
0.100
Why?
Equipment Design
1
2013
138
0.100
Why?
Tamoxifen
1
1993
30
0.100
Why?
Breast
3
1998
28
0.100
Why?
Magnetic Resonance Imaging
3
2016
1112
0.100
Why?
Biopsy
2
2007
201
0.100
Why?
House Calls
2
2022
15
0.100
Why?
Double-Blind Method
1
2013
406
0.100
Why?
Neurologic Examination
3
2008
100
0.100
Why?
Infant, Newborn
2
2021
642
0.090
Why?
Genome-Wide Association Study
2
2023
280
0.090
Why?
Social Behavior Disorders
1
2011
5
0.090
Why?
Language Disorders
1
2011
7
0.090
Why?
Memantine
1
2010
9
0.090
Why?
Cyclohexanols
1
2010
18
0.090
Why?
Mammography
4
1998
47
0.090
Why?
Cocaine
1
2010
31
0.090
Why?
Point Mutation
2
2008
25
0.090
Why?
Odds Ratio
1
2011
270
0.090
Why?
Corpus Striatum
1
2010
65
0.080
Why?
Tomography, Emission-Computed, Single-Photon
1
2010
79
0.080
Why?
Family Health
2
2007
34
0.080
Why?
Herpes Zoster
1
2009
4
0.080
Why?
Atmospheric Pressure
2
2019
6
0.080
Why?
Brown-Sequard Syndrome
1
2009
4
0.080
Why?
Aripiprazole
1
2009
7
0.080
Why?
Atrophy
2
2008
91
0.080
Why?
Biomarkers
2
2022
562
0.080
Why?
Palate, Soft
1
2008
1
0.070
Why?
Alexander Disease
1
2008
1
0.070
Why?
Heredodegenerative Disorders, Nervous System
1
2008
2
0.070
Why?
Genetic Carrier Screening
1
2007
10
0.070
Why?
Child, Preschool
1
2009
641
0.070
Why?
Exercise Tolerance
1
2007
31
0.070
Why?
Guidelines as Topic
1
2007
57
0.070
Why?
Glutens
1
2007
1
0.070
Why?
Jejunum
1
2007
10
0.070
Why?
Chromosome Mapping
1
2007
42
0.070
Why?
Research Support as Topic
1
2007
14
0.070
Why?
National Institutes of Health (U.S.)
1
2007
25
0.070
Why?
Education
1
2007
40
0.070
Why?
North America
2
2018
41
0.070
Why?
Universities
1
2007
39
0.070
Why?
Carbidopa
1
2006
4
0.070
Why?
Peripheral Nervous System Diseases
1
2007
28
0.070
Why?
Tomography, X-Ray Computed
2
2004
683
0.070
Why?
Cholinesterase Inhibitors
1
2006
14
0.070
Why?
Benzodiazepines
1
2006
46
0.070
Why?
Adrenergic beta-Antagonists
1
2006
26
0.070
Why?
Internet
1
2007
91
0.060
Why?
Intestinal Mucosa
1
2007
156
0.060
Why?
Population Surveillance
1
2006
115
0.060
Why?
Syndrome
1
2005
76
0.060
Why?
Pregnancy
1
2006
336
0.060
Why?
Cerebellum
1
2005
43
0.060
Why?
Anxiety Disorders
1
2006
171
0.060
Why?
Health Surveys
1
2005
86
0.060
Why?
RNA-Binding Proteins
1
2004
24
0.060
Why?
Disease Models, Animal
2
2019
599
0.050
Why?
Linkage Disequilibrium
1
2023
43
0.050
Why?
Agraphia
1
2003
1
0.050
Why?
Dyslexia, Acquired
1
2003
1
0.050
Why?
Auditory Perceptual Disorders
1
2003
2
0.050
Why?
Genetic Loci
1
2023
51
0.050
Why?
Metagenome
1
2023
17
0.050
Why?
Nerve Tissue Proteins
1
2004
154
0.050
Why?
Uterine Diseases
1
2002
2
0.050
Why?
Mentors
1
2022
36
0.050
Why?
Guanine
1
2022
5
0.050
Why?
Endometriosis
1
2002
16
0.050
Why?
Task Performance and Analysis
2
2013
47
0.050
Why?
Polymorphism, Single Nucleotide
1
2023
278
0.050
Why?
Butyrates
1
2022
17
0.050
Why?
Neurons
1
2005
339
0.050
Why?
Practice Guidelines as Topic
2
2021
261
0.050
Why?
Stroke
1
2005
261
0.050
Why?
Dysbiosis
1
2022
45
0.050
Why?
Bacteria
1
2022
70
0.050
Why?
Peptides
1
2022
102
0.050
Why?
Genetic Background
1
2021
2
0.050
Why?
Physical Therapy Modalities
2
2012
74
0.050
Why?
Drosophila melanogaster
1
2021
15
0.050
Why?
Animals, Genetically Modified
1
2021
19
0.050
Why?
Fertility
1
2021
18
0.050
Why?
Cross-Over Studies
1
2021
64
0.040
Why?
Proteome
1
2021
41
0.040
Why?
Hydrogen-Ion Concentration
1
2021
143
0.040
Why?
Surface Properties
1
2021
135
0.040
Why?
Life Style
1
2022
186
0.040
Why?
Corrosion
1
2021
126
0.040
Why?
Materials Testing
1
2021
129
0.040
Why?
Inflammation
1
2022
272
0.040
Why?
Databases, Factual
1
2022
347
0.040
Why?
Noise
1
2020
24
0.040
Why?
Feasibility Studies
1
2020
220
0.040
Why?
Logistic Models
2
2018
395
0.040
Why?
Cochlear Implants
1
2020
28
0.040
Why?
Nerve Degeneration
1
2019
48
0.040
Why?
Biopsy, Needle
2
1996
105
0.040
Why?
Temperature
1
2018
63
0.040
Why?
Prosthesis Design
1
2021
490
0.040
Why?
Risk Assessment
1
2021
624
0.040
Why?
Breast Diseases
1
1998
7
0.040
Why?
Hospitalization
1
2020
300
0.040
Why?
Prognosis
1
2020
785
0.040
Why?
Mice, Inbred C57BL
1
2019
420
0.040
Why?
Comorbidity
1
2019
481
0.040
Why?
Prosthesis Failure
1
2021
523
0.030
Why?
Self Report
1
2018
223
0.030
Why?
Accelerometry
1
2017
89
0.030
Why?
Posture
1
2016
63
0.030
Why?
Protective Factors
1
2016
26
0.030
Why?
Occupational Exposure
1
2016
17
0.030
Why?
Radiography, Interventional
1
1996
17
0.030
Why?
Practice Patterns, Physicians'
1
1997
111
0.030
Why?
Neuroimaging
1
2016
126
0.030
Why?
Mice
1
2019
1395
0.030
Why?
Video Recording
1
2014
31
0.030
Why?
Single-Blind Method
1
2013
102
0.030
Why?
Movement
1
2013
112
0.030
Why?
Socioeconomic Factors
1
2013
302
0.020
Why?
Mental Health
1
2013
108
0.020
Why?
Health Status
1
2013
218
0.020
Why?
Statistics, Nonparametric
1
2011
125
0.020
Why?
Chi-Square Distribution
1
2011
139
0.020
Why?
Mass Screening
2
2007
167
0.020
Why?
Venlafaxine Hydrochloride
1
2010
17
0.020
Why?
Linear Models
1
2011
247
0.020
Why?
Drug Therapy, Combination
1
2010
161
0.020
Why?
Geniculate Ganglion
1
2009
1
0.020
Why?
Superior Cervical Ganglion
1
2009
1
0.020
Why?
Pons
1
2008
5
0.020
Why?
Intelligence
1
2008
18
0.020
Why?
Mental Processes
1
2008
17
0.020
Why?
Verbal Learning
1
2008
33
0.020
Why?
Glial Fibrillary Acidic Protein
1
2008
43
0.020
Why?
Gene Silencing
1
2007
23
0.020
Why?
Patient Compliance
1
2007
150
0.020
Why?
California
1
2004
34
0.010
Why?
Leiomyoma
1
2002
5
0.010
Why?
Uterine Neoplasms
1
2002
11
0.010
Why?
Ultrasonography
1
2002
227
0.010
Why?
Diagnostic Tests, Routine
1
1998
12
0.010
Why?
Age Distribution
1
1996
85
0.010
Why?
Palpation
1
1996
4
0.010
Why?
Hall's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (384)
Explore
_
Co-Authors (40)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_
Physical Neighbors
_